COVID-19 impact on Pharma

The COVID-19 outbreak has now spread around the world, leaving a trail of destruction in its wake. The pandemic has already changed how we work and how we live our lives. Many of these changes will have long-term implications. Companies in every sector, including Pharma, will need to adopt new technologies and new ways of working as they adapt to these new realities.

In partnership with

Deal trends in the Pharma sector during COVID-19

Clinical Trials Arena’s COVID-19 deal tracker monitors deals that took place across the Pharma sector during the pandemic.

Deals trends in the Pharma sector: Q1 2020 – Q1 2022

182,340 Grant

Total Value US$m: 82,311.9
YOY Change: -36.3%

6,523 Contract Service Agreement

Total Value US$m: 2,643.5
YOY Change: -33.0%

5,678 Venture Financing

Total Value US$m: 141,693.5
YOY Change: -38.9%

5,081 Equity Offering

Total Value US$m: 461,379.8
YOY Change: -26.0%

3,530 Partnership

Total Value US$m: 170,978.9
YOY Change: -

2,479 Licensing Agreement

Total Value US$m: 365,052.6
YOY Change: -17.5%

1,622 Acquisition

Total Value US$m: 520,578.6
YOY Change: -22.5%

942 Private Equity

Total Value US$m: 103,717
YOY Change: -62.6%

817 Debt Offering

Total Value US$m: 354,257.7
YOY Change: -39.6%

565 Asset Transaction

Total Value US$m: 42,100.3
YOY Change: -22.9%

197 Merger

Total Value US$m: 28,871.2
YOY Change: 89.3%

Innovation in the Pharma sector during COVID-19

To best track innovation in response to COVID-19’s impact on the Pharma sector, Clinical Trials Arena tracks the patent applications, as well as the patent applicants throughout the COVID-19 pandemic.

Number of patents in the Pharma sector: Q1 2018 – Q1 2022

The COVID-19 patents tracker in the Pharma sector monitors the patent applications pre- and post-outbreak.

Note: Application counts are based on publications. Patent applications which are not published yet are not considered for analysis. Publication may take up to 18 months from the application of patents.

Top Patent Applicants in the Pharma sector: Pre-COVID-19 (Filing Year 2018 – 2019)

Clinical Trials Arena patent ownership data monitors the patent applicants in the sector before the COVID-19 outbreak.

Top Patent Applicants in the Pharma sector: Post-COVID-19 (Filing Year 2020 – Q1 2022)

Clinical Trials Arena patent ownership data monitors the patent applicants in the sector after the COVID-19 outbreak.

Note: Application counts are based on publications. Patent applications which are not published yet are not considered for analysis. Publication may take up to 18 months from the application of patents.

Number of COVID-19 mentions in filings in the Pharma sector: Q1 2020 – Q1 2022

Clinical Trials Arena tracks thousands of companies and their annual and quarterly filings. Our analysis monitors the mentions of COVID-19 in those filings during the pandemic.

COVID-19 versus top 5 themes in Pharma

Clinical Trials Arena compares COVID-19 mentions in filings with other top themes in filings data during the pandemic.

Top 10 companies with COVID-19 mentions in filings

Clinical Trials Arena tracks which pharmaceutical companies mention COVID-19 in filings the most during the pandemic.

Jobs insights in the Pharma sector during COVID-19

Clinical Trials Arena monitors live pharma company jobs postings to assess the impact of COVID-19 on the sector.

Job trends in the Pharma sector

Jobs postings by pharmaceutical companies after the outbreak. The COVID-19 jobs tracker in the Pharma sector looks at jobs posted, closed and active to assess the impact of the pandemic on sector jobs.

Most active Pharma companies: Jobs

Clinical Trials Arena’s Pharma jobs tracker lists pharmaceutical companies with the most jobs posted during the COVID-19 period.

Pharma influencer discussions on COVID-19

Clinical Trials Arena tracks the mentions of COVID-19 by leading Pharma influencers on Twitter. The chart indicates the volume of tweets and influencers pertaining to COVID-19.

Banner